Medical Plastic Data Service Magazine



Our 28th Year of Publication
Page  4 of 7

Cover Story

Indian Diagnostics Industry -
Challenges & Opportunities Post Corona Pandemic

Jatin Mahajan
Managing Director, J Mitra and Co.

Jatin Mahajan, the managing director of J Mitra & Company has been at the centre of action as a leading global IVD player, preparing for the extensive war against the corona disease. In a free-wheeling interview to Medical Plastics, Jatin Mahajan shares his views and thoughts about the industry...

Corona – Challenges Or Possibilities

  • Our next generations will not be able to imagine life as it was before corona.

  • I have a very positive outlook for the Indian healthcare industry.

  • There is the possibility of the world focus shifting to India as the primary producer and supplier of APIs, IVDs and generic drug.

  • The criticality and yeoman services of the Indian IVD industry are being re-established, recognised and appreciated.

  • In the history of mankind this is the first time that diagnostics industry has been in the absolute spotlight.

  • The world has recognised the need for early warning systems (Diagnostics) in the healthcare segment, and this trend is going to continue.

  • Our cost-effective, society-conscious and ethical business dealings will further cement our reputation and relationship with our publics.

Challenges Of A Diagnostics Company During Corona (and Earlier)

  • Our story has been about constant analysis, introspection, innovation and transformation.

  • Made our systems & processes very sound and robust.

  • We have a very stringent audit and reporting mechanism

  • We have continued to focus on our people’s well being and progress.

  • Policy issues have continued to hamper our work, especially the inverted tax policy wherein raw materials are taxes more than finished products in our segment.

Expectations From The Government

  • Cut down import duty on raw materials and hike import duty on finished goods

  • ELISA finished products have 0% duty and 5% IGST, whereas the raw material for ELISA kits attract 5-20% import duty plus 12% IGST – tilting the balance away from the home-grown manufacturers.

  • The availability of samples for testing is another great concern.

  • Aspects critical for winning the race in the global healthcare space are – ensuring a cost advantage over other nations, faster government permissions and single-window clearances, ease of doing business, adequate financing, competent infrastructure and soft loans with longer repayments.

Widespread mushrooming of pathology labs

  • Proliferation of the pathological labs in the country is a boon for the masses.

  • Distance between patients and point of care should be mitigated.

  • NABL as a quality-certification and assurance organization is ensuring that they bring all large and small patho- logical laboratories within their ambit.

Genesis Of The Company & Professional Journey

  • J Mitra & Company was established in 1969.

  • My focus towards consolidation of the domestic business, increasing the international footprint, driving business strategy, Sales & Marketing, product development and customer service through constant innovation and automations.

  • We export to over 45 countries across the globe.

  • We have a strong R&D team, and over 55 patents, the highest for any company in India.

Jatin’s Corporate Roles & Responsibilities

  • Innovation and business foresight are extremely important for the survival of any business.

  • A robust business continuity plan is a must to mitigate the negative impact of large-scale disruptions. Standard operating procedures help in ensuring that most of the concern aspects have been thought of, ideated, and actionable defined.

  • Flexibility and adaptability must be incorporated in the business ethos.

  • To mitigate heartaches in a business arena, we have focused on 4 key areas - Integrity & Fair Play; Quality; R&D; Innovation and Perseverance and Staying ahead of the Competition.

Back | Back to Top | Previous | Next

Advertisers' Index

Accuprec Research Labs Pvt. Ltd., India
Ambica Medicare Engineering, India
Nu-Vu Conair Pvt. Ltd., India
Divya Steri Solutions Pvt. Ltd., India
ET Elastomer Technik, Germany
Eewa Engineering Co. Pvt. Ltd., India
Ineos Styrolution India Ltd., India
I-Kare Polyalloys Pvt. Ltd., India
KLJ Group, India
Lubrizol Advanced Materials India Pvt. Ltd.
Kuraray India Pvt. Ltd., India
Maider Medical Industry Equipment Ltd.China
Medicall 2019, India
Ferromatik Milacron India Pvt. Ltd., India
GLR Laboratories Pvt. Ltd., India
Pashiba Lifescience, India
Plastivision India
Pradeep Surgipack, India
PVC Colouring Compounding & Processing, India
Qosina, USA
Raumedic AG
SMC Medical Manufacturing Pvt. Ltd., India
Sterimed Medical Devices (P) Ltd., India
Steri Techno Fab, India
Tekni-Plex India Pvt. Ltd., India
Twist Engineering Works,India
Yuhuan Shengjiu Mould Co., Ltd., China

Airways Surgical Pvt. Ltd., India

Alpha Medicare and Devices Ltd., India
Alpha Therapeutics Pvt. Ltd., India
Ami Polymer Pvt. Ltd., India
Angiplast Pvt. Ltd., India
Appasamy Associates, India
Beacon Plastics, India
Delux Surgical, Inida
Ignisol Mediplas Corporation, India
Jain Rubbers Pvt. Ltd., India
Operon Strategist, India
R.R. Patel Gases (P) Ltd., India

Proven Trade Contacts, India

Sanidhya Enterprise, India
Surgi Pack India Pvt. Ltd.
Unikal Consultants, India
Vinit Performance Polymers Pvt. Ltd., India
Aircity, India
Amigo Surgi Care Pvt. Ltd., India
Angel Products, India
Apex Medical Devices, India
Jimit Medico Surgicals Pvt. Ltd.
Kavya Packaging, India
Life-O-Line Technologist, India
Mesco Surgical, India
Morrisons Lifecare Pvt. Ltd., India
National Healthcare, India
Pharmadocx, Inida
S. Nath & Co., India
Unikal Consultants, India
Venus Industries,India, Mobile : 9825747495
Zinkal Products, India